Alzheimer's disease

For Eisai and Biogen's Leqembi, first FDA-approved Alzheimer's blood test will take time to boost launch: analyst
Fierce Pharma
Mon, 05/19/25 - 10:25 pm
Eisai
Biogen
Alzheimer's disease
Leqembi
diagnostics
FDA clears its first blood test for diagnosing Alzheimer's disease, with Fujirebio's Lumipulse
Fierce Biotech
Sun, 05/18/25 - 10:38 pm
Fujirebio Diagnostics
FDA
Alzheimer's disease
diagnostics
Lumipulse G
Eisai Projects Significant Growth for Alzheimer’s Drug Leqembi
Tip Ranks
Thu, 05/15/25 - 10:31 pm
Eisai
Alzheimer's disease
Leqembi
Alector concludes enrollment in Phase II trial of Alzheimer’s treatment
Clinical Trials Arena
Mon, 04/21/25 - 06:06 pm
clinical trials
Alector
GSK
Alzheimer's disease
AL101
Leqembi is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
Stock Titan
Tue, 04/15/25 - 07:49 pm
Leqembi
Alzheimer's disease
Europe
Biogen
Eisai
Alzheon Alzheimer's drug knocked down in pivotal APOLLOE4 bout
Fierce Biotech
Thu, 04/10/25 - 11:43 am
Alzheon
Alzheimer's disease
tramiprosate
clinical trials
US vs. EU: When it comes to novel Alzheimer’s drugs, regulators can’t seem to agree
Pharma Voice
Mon, 04/7/25 - 10:06 am
Europe
Biogen
Eisai
Leqembi
Alzheimer's disease
Roche preps phase 3 for 'Brainshuttle' Alzheimer's drug
Pharmaphorum
Mon, 04/7/25 - 10:05 am
Roche
clinical trials
Alzheimer's disease
trontinemab
FDA Grants Fast Track Designation to Biogen’s Novel Alzheimer Disease Drug Candidate
Pharm Exec
Thu, 04/3/25 - 11:28 am
Biogen
BIIB080
FDA
fast track
Alzheimer's disease
European committee says Lilly Alzheimer's drug shouldn't get marketing approval
Yahoo/AP
Fri, 03/28/25 - 11:13 am
Eli Lilly
Kisunla
Europe
Alzheimer's disease
EMA
Lilly adds Alzheimer’s disease care to DTC telehealth platform
Fierce Pharma
Thu, 03/27/25 - 10:40 pm
Eli Lilly
LillyDirect
DTC
Alzheimer's disease
Acumen concludes enrolment in Phase II trial of sabirnetug for Alzheimer’s
Clinical Trials Arena
Thu, 03/27/25 - 11:12 am
Acumen Pharmaceuticals
clinical trials
sabirnetug
Alzheimer's disease
Eisai lays out road map to blockbuster sales projections for Leqembi's 'milestone' 2027 year
Fierce Pharma
Tue, 03/25/25 - 09:43 pm
Eisai
Leqembi
Alzheimer's disease
Cassava Sciences' controversial Alzheimer's drug fails in second late-stage study
Reuters
Tue, 03/25/25 - 11:24 am
Cassava Sciences
clinical trials
simufilam
Alzheimer's disease
Roche's gantenerumab 'shows sign of preventing Alzheimer's dementia'
Pharmaphorum
Thu, 03/20/25 - 09:56 am
Roche
gantenerumab
clinical trials
Alzheimer's disease
NICE agrees to look again at Alzheimer's drug Leqembi
Pharmaphorum
Thu, 03/6/25 - 10:59 am
Eisai
Biogen
Leqembi
Alzheimer's disease
UK
NICE
New tau candidates, including an RNA therapy from Voyager, drive a multi-pronged Alzheimer’s approach
Pharma Voice
Tue, 03/4/25 - 09:51 am
Voyager Therapeutics
RNA
Alzheimer's disease
Eisai
Biogen
Eli Lilly
Australia stands firm on 'no' to Alzheimer's drug Leqembi
Pharmaphorum
Mon, 03/3/25 - 10:53 am
Eisai
Biogen
Australia
Alzheimer's disease
Leqembi
Leqembi, after delay, gets back on track toward EU approval
BioPharma Dive
Sun, 03/2/25 - 09:35 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
Europe
Eisai execs flag Leqembi 'expansion phase' on the horizon as Alzheimer's med grows slowlym
Fierce Pharma
Tue, 02/11/25 - 09:41 pm
Eisai
Leqembi
Alzheimer's disease

Pages